Market Place
Sourcing Support
Forge Biologics Launches FUEL™ AAV Manufacturing Platform
02 Oct 2024 //
BUSINESSWIRE
Forge Biologics Launches FUEL Manufacturing Platform
02 Oct 2024 //
CONTRACT PHARMA
Forge Biologics Names New CEO
10 Sep 2024 //
CONTRACT PHARMA
Forge Biologics to Support MDA’s Kickstart Program
10 Sep 2024 //
CONTRACT PHARMA
Forge Biologics Announces Planned CEO Succession
10 Sep 2024 //
BUSINESSWIRE
MDA And Forge Biologics Partner On AAV Development
09 Sep 2024 //
BUSINESSWIRE
Ajinomoto lay off 71 staffers in CA to CDMO business following $620M Forge buy
12 Aug 2024 //
FIERCE PHARMA
Ajinomoto To Lay Off 71 In CA After $620M Forge Biologics Acquisition
12 Aug 2024 //
FIERCE PHARMA
Forge Announces 9 Presentations At ASGCT Annual Meeting
30 Apr 2024 //
BUSINESSWIRE
Forge Biologics’ Novel AAV Gene Therapy FBX-101 for Patients with Krabbe Disease
19 Mar 2024 //
BUSINESSWIRE
Forge’s AAV Gene Therapy Granted Innovation Passport Designation Krabbe Disease
19 Mar 2024 //
CONTRACT PHARMA
Forge Biologics Announces Positive FBX-101 Clinical Trial Update
29 Jan 2024 //
BUSINESSWIRE
Forge Biologics Announces Publication in Human Gene Therapy
12 Dec 2023 //
BUSINESSWIRE
New acquisition to support global gene therapy manufacturing
15 Nov 2023 //
EUROPEAN PHARMACEUTICAL REVIEW
CDMO Ajinomoto forges ahead with Forge Biologics in $620M acquisition
13 Nov 2023 //
FIERCE PHARMA
Forge blazes into collaboration to bolster AAV gene therapies
12 Oct 2023 //
FIERCE PHARMA
Forge Biologics Selected as AAV Manufacturing Partner for California Institute
11 Oct 2023 //
BUSINESSWIRE
Forge Biologics to Participate in Multiple September Investor Conferences
05 Sep 2023 //
BUSINESSWIRE
New Hope Research & Forge Announce cGMP Mfg Partnership for Gene Therapy
28 Jun 2023 //
BUSINESSWIRE
New Hope Research, Forge Biologics Enter cGMP Manufacturing Pact
28 Jun 2023 //
CONTRACT PHARMA
Forge Biologics Joins BGTC as Partner to Develop AAV Gene Therapies
23 May 2023 //
BUSINESSWIRE
Forge Biologics Announces Eight Presentations at the ASGCT
11 May 2023 //
BUSINESSWIRE
Quality issues at Sun Pharma plant; Forge secures manufacturing contract
11 May 2023 //
ENDPTS
Forge fires up gene therapy production partnership with Life Bio
09 May 2023 //
FIERCE PHARMA
Life Biosciences, Forge Biologics Partner to Advance Gene Therapies
08 May 2023 //
CONTRACT PHARMA
Forge Biologics and Labcorp partner for gene therapies development
04 May 2023 //
PHARMACEUTICAL TECHNOLOGY
Forge Biologics Partners with Labcorp on AAV Gene Therapy Development
03 May 2023 //
BUSINESSWIRE
Forge Biologics secures manufacturing and development deal with LabCorp
03 May 2023 //
ENDPTS
Forge Biologics Reports Positive FBX-101 Updates for Patients
23 Feb 2023 //
BUSINESSWIRE
Forge Deepens Genetic Medicine CDMO Capabilities with Leadership Team Expansion
25 Jan 2023 //
BUSINESSWIRE
Forge Biologics Receives PRIME Designation from EMA for Novel Gene Therapy
20 Jan 2023 //
CONTRACT PHARMA
Forge Receives Priority Medicines Designation from the EMA for FBX-101
17 Jan 2023 //
BUSINESSWIRE
Forge Biologics to Present at 41st Annual J.P. Morgan Healthcare Conference
04 Jan 2023 //
BUSINESSWIRE
Forge Biologics Announces Updated Positive Clinical Data in RESKUE
11 Oct 2022 //
BUSINESSWIRE
Ray Therapeutics and Forge Biologics Expand Their Viral Vector cGMP Partnership
10 Oct 2022 //
BUSINESSWIRE
Myrtelle and Forge Biologics Form Manufacturing Partnership
07 Oct 2022 //
CONTRACTPHARMA
CNS-focused gene therapy biotech forges manufacturing deal for hearing loss drug
06 Oct 2022 //
ENDPTS
Forge Biologics to Present and Participate at Upcoming Investor Conferences
29 Sep 2022 //
BUSINESSWIRE
Forge Biologics Launch Plasmid DNA Manufacturing Services
27 Sep 2022 //
BUSINESSWIRE
Forge continues streak with $90M round for gene therapy manufacturing services
13 Sep 2022 //
ENPTS
Forge Biologics Reports Positive Clinical Data on Brain DevP & Motor Function
30 Aug 2022 //
BUSINESSWIRE
Forge Biologics to Present at Annual Jefferies Global Healthcare Conference
31 May 2022 //
BUSINESSWIRE
Forge Biologics Forms Independent Scientific and Manufacturing Advisory Board
17 May 2022 //
BUSINESSWIRE
Forge Biologics Announces 7 Presentations at the Upcoming ASGCT
02 May 2022 //
BUSINESSWIRE
Forge Biologics to Present at Chardan’s 6th AGM and CTM Summit
14 Apr 2022 //
BUSINESSWIRE
Forge Biologics to Participate in Upcoming Investor Conferences
07 Mar 2022 //
BUSINESSWIRE
Ray Tx, Forge Biologics Enter Gene Therapy Mfg. Pact
01 Mar 2022 //
CONTRACTPHARMA
Ray Tx, Forge Biologics Announce Viral Vector Contract Development
01 Mar 2022 //
BUSINESSWIRE
Forge Biologics Closes $80M in Additional Financing for CDMO Expansion
10 Jan 2022 //
BUSINESSWIRE
Solid Biosciences,Forge Biologics Enter Development &Manufacturing Partnership
05 Oct 2021 //
CONTRACTPHARMA
Solid Biosciences and Forge Biologics Announce Partnership
04 Oct 2021 //
BUSINESSWIRE
Solid Biosciences and Forge Biologics Announce Partnership
04 Oct 2021 //
BUSINESSWIRE
Forge Biologics publishes regulatory updates from FDA and EMA
20 Sep 2021 //
BUSINESSWIRE
Forge Biologics Expands Leadership Team
31 Aug 2021 //
CONTRACT PHARMA
Forge Biologics Announces Key Hires in CDMO Operations and Medical Affairs
25 Aug 2021 //
BUSINESSWIRE
GentiBio, Forge Biologics Ink Development and Manufacturing Agreement
19 Jul 2021 //
CONTRACT PHARMA
Forge Biologics to Present at 2021 BIO Digital Conference
10 Jun 2021 //
BUSINESSWIRE
Forge Biologics Appoints John Maslowski as Chief Commercial Officer
03 Jun 2021 //
BIOSPACE
Forge Biologics to Present at the American Society of Gene Cell Therapy’s 24th
11 May 2021 //
BUSINESSWIRE
Forge Biologics Announces Closing of $120 Million Series B Financing
29 Apr 2021 //
BUSINESSWIRE
